Investor
The firm plans to further develop its blood typing technology.
The Series C brings its total raise to $160 million.
Funding will help take its DTx solutions through regulatory approvals and to market in the UK and US.
Global healthtech has received $51.3 billion in investment this year, marking new highs for venture capitalist interest in the sector and identifying London as the fastest growing healthtech hub globally.
2021 Year in Review
Also: RenalSense scores $14 million for its renal diagnostic, and InsurMedix rakes in $15 million for fertility insurance.
The resignation comes a week after the company announced its cofounders were leaving their roles.
The news comes just as Pear is finalizing its SPAC merger.
SWORD raised $163 million in Series D funding, which allowed for a secondary round where it scooped up another $26 million.
Digital infrastructure company Lifen has raised $58M (€51M) in funding, which will go towards working with 1,500 hospitals and 200 eHealth solutions by 2025.